TRCT
PASG icon

Tower Research Capital (TRC)’s Passage Bio PASG Stock Holding History

Tower Research Capital (TRC)’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-502
Closed -$3.94K – 5530
2026
Q1 		$3.94K Buy
+502
New +$5.2K ﹤0.01% 4245
2025
Q4 		– Sell
-289
Closed -$2.32K – 5468
2025
Q3 		$2.32K Sell
289
-1,175
-80% -$8.18K ﹤0.01% 4649
2025
Q2 		$11.7K Buy
1,464
+1,148
+363% +$8.39K ﹤0.01% 3904
2025
Q1 		$2.23K Sell
316
-2,408
-88% -$26K ﹤0.01% 4574
2024
Q4 		$30.9K Buy
2,724
+2,472
+981% +$32.2K ﹤0.01% 2883
2024
Q3 		$3.52K Sell
252
-408
-62% -$6.5K ﹤0.01% 4829
2024
Q2 		$10.5K Buy
660
+658
+32,900% +$16.1K ﹤0.01% 4146
2024
Q1 		$46 Buy
+2
New +$48 ﹤0.01% 5713
2023
Q4 		– Sell
-686
Closed -$9.03K – 6105
2023
Q3 		$9.03K Buy
686
+557
+432% +$9.15K ﹤0.01% 4275
2023
Q2 		$2.42K Sell
129
-1,523
-92% -$30.1K ﹤0.01% 5202
2023
Q1 		$32K Sell
1,652
-528
-24% -$14.3K ﹤0.01% 2929
2022
Q4 		$60K Buy
2,180
+99
+5% +$2.5K ﹤0.01% 2207
2022
Q3 		$52K Buy
2,081
+985
+90% +$38.8K ﹤0.01% 3129
2022
Q2 		$51K Buy
1,096
+320
+41% +$14.9K ﹤0.01% 2863
2022
Q1 		$48K Buy
776
+696
+870% +$57.4K ﹤0.01% 2768
2021
Q4 		$10K Sell
80
-29
-27% -$4.74K ﹤0.01% 4594
2021
Q3 		$22K Sell
109
-198
-64% -$47.2K ﹤0.01% 3636
2021
Q2 		$81K Buy
307
+151
+97% +$46.7K ﹤0.01% 2595
2021
Q1 		$55K Buy
156
+112
+255% +$47.8K ﹤0.01% 3048
2020
Q4 		$23K Sell
44
-575
-93% -$230K ﹤0.01% 3778
2020
Q3 		$162K Buy
619
+580
+1,487% +$200K ﹤0.01% 2761
2020
Q2 		$21K Buy
39
+32
+457% +$14.4K ﹤0.01% 3655
2020
Q1 		$2K Buy
+7
New +$2.19K ﹤0.01% 2617

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $291M AUM 19.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VA
Verdad Advisers Boston, Massachusetts $104M AUM
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Tower Research Capital (TRC)'s PASG Position: Q2 2026 in Review

Tower Research Capital (TRC) sold out of Passage Bio (PASG) in Q2 2026, closing a stake of 502 shares — an estimated $3.94K sold.

Tower Research Capital (TRC) first reported a position in PASG in Q1 2020 and held it in 23 quarters. The position peaked at $162K in Q3 2020. 29 funds tracked by Wall St. Rank hold PASG as of Q2 2026.

  • Tower Research Capital (TRC) reported no remaining Passage Bio position as of Q2 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 502 Passage Bio shares in Q2 2026, an estimated $3.94K.
  • Tower Research Capital (TRC) first reported a position in Passage Bio in Q1 2020 and held it in 23 quarters.
  • Tower Research Capital (TRC)'s Passage Bio position peaked at $162K in Q3 2020.
  • 29 funds tracked by Wall St. Rank held Passage Bio as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.